APA (7th ed.) Citation

Curry, J. L., Reuben, A., Szczepaniak‐Sloane, R., Ning, J., Milton, D. R., Lee, C. H., . . . Tetzlaff, M. T. (2019). Gene expression profiling of lichenoid dermatitis immune‐related adverse event from immune checkpoint inhibitors reveals increased CD14+ and CD16+ monocytes driving an innate immune response. Journal of Cutaneous Pathology, 46(9), 627. https://doi.org/10.1111/cup.13454

Chicago Style (17th ed.) Citation

Curry, Jonathan L., et al. "Gene Expression Profiling of Lichenoid Dermatitis Immune‐related Adverse Event from Immune Checkpoint Inhibitors Reveals Increased CD14+ and CD16+ Monocytes Driving an Innate Immune Response." Journal of Cutaneous Pathology 46, no. 9 (2019): 627. https://doi.org/10.1111/cup.13454.

MLA (9th ed.) Citation

Curry, Jonathan L., et al. "Gene Expression Profiling of Lichenoid Dermatitis Immune‐related Adverse Event from Immune Checkpoint Inhibitors Reveals Increased CD14+ and CD16+ Monocytes Driving an Innate Immune Response." Journal of Cutaneous Pathology, vol. 46, no. 9, 2019, p. 627, https://doi.org/10.1111/cup.13454.